The Intellectual Property & Science business of Thomson Reuters has announced an extension of its relationship with One Mind™ for Research to further the understanding of the central nervous system (CNS) and traumatic brain injuries (TBI) through tranSMART. tranSMART is an open source data sharing and analytics platform supported by the tranSMART Foundation.
One Mind is working with Thomson Reuters to implement tranSMART, to support the scientific community's need to share data, collaborate to improve diagnostics and discover more effective treatments for patients suffering from CNS- and TBI-related diseases. In the first stages of the project, the Thomson Reuters Life Sciences Professional Services team provided data curation and analysis for preparing and uploading TBI clinical data, performing preliminary data analyses and designing a workflow driven by clinical terminology.
In the next stage, the Thomson Reuters team will provide a broad spectrum of services to assist One Mind and its partners in using the platform as part of the One Mind Portal, including advanced bioinformatics analysis of the molecular data generated in TBI, clinical trials and a customization of tranSMART for an organisation's information portals. Thomson Reuters and One Mind look to continue the relationship in the future for the development of the 'Apollo Program,' the One Mind Brain Data Exchange Portal.
tranSMART is specifically designed to be an environment where life scientists and bioinformaticians can store patient data and correlate it with phenotypic data of clinical relevance, such as disease subtypes, drug response and survival expectancy. Researchers will then be able to use the platform to generate hypotheses on efficacy and toxicity biomarkers, novel drug targets, patient stratification for clinical trials, and other clinical applications.
Thomson Reuters Life Sciences Professional Services is a multi-disciplinary team of molecular biologists, bioinformaticians, medicinal chemists and IT engineers.
